Anteris Technologies Global Corp’s (NASDAQ:AVR) Quiet Period To Expire on January 22nd

Anteris Technologies Global’s (NASDAQ:AVR) quiet period is set to end on Wednesday, January 22nd. Anteris Technologies Global had issued 14,800,000 shares in its public offering on December 13th. The total size of the offering was $88,800,000 based on an initial share price of $6.00. During Anteris Technologies Global’s quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Analysts Set New Price Targets

A number of analysts have commented on the company. TD Cowen assumed coverage on Anteris Technologies Global in a report on Tuesday, January 7th. They set a “buy” rating and a $15.00 price objective for the company. Lake Street Capital assumed coverage on shares of Anteris Technologies Global in a research report on Wednesday, January 8th. They issued a “buy” rating and a $20.00 price objective on the stock. Cantor Fitzgerald started coverage on Anteris Technologies Global in a research note on Tuesday, January 7th. They set an “overweight” rating and a $9.00 price target for the company. Finally, Barclays started coverage on shares of Anteris Technologies Global in a report on Tuesday, January 7th. They set an “overweight” rating and a $22.00 target price on the stock.

Anteris Technologies Global Stock Performance

Shares of NASDAQ:AVR opened at $5.99 on Friday. Anteris Technologies Global has a 12 month low of $5.10 and a 12 month high of $6.10.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.